Septerna (SEPN) Other Non Operating Income (2023 - 2026)

Septerna's quarterly Other Non Operating Income came in at -$31000.0 in Q1 2026, down 10.71% year-on-year from -$34720.0 in Q1 2025, and up 24.39% quarter-over-quarter from -$41000.0 in Q4 2025.

Septerna has reported Other Non Operating Income for 4 years, with the latest figure at -$31000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Other Non Operating Income fell 10.71% year-over-year to -$31000.0; the trailing twelve-month figure through Mar 2026 stood at -$103000.0 (down 47.14% YoY), and the FY2025 full-year result was -$100000.0, down 11.11% from the prior year.
  • Other Non Operating Income for Q1 2026 stood at -$31000.0, up from -$41000.0 in the prior quarter.
  • The five-year high for Other Non Operating Income was $13000.0 in Q4 2023, with the low at -$48000.0 in Q1 2024.
  • Average Other Non Operating Income over 4 years is -$19000.0, with a median of -$18000.0 recorded in 2024.
  • Year-over-year, Other Non Operating Income plunged 800.0% in 2024 and soared 41.67% in 2025.
  • Tracing SEPN's Other Non Operating Income over 4 years: stood at $13000.0 in 2023, then slumped by 238.46% to -$18000.0 in 2024, then tumbled by 127.78% to -$41000.0 in 2025, then rose by 24.39% to -$31000.0 in 2026.
  • The last three Other Non Operating Income figures came in at -$31000.0 (Q1 2026), -$41000.0 (Q4 2025), and -$6000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Septerna 1.34 Bn 1.34 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -31,000.00
Dec 31, 2025 -41,000.00
Sep 30, 2025 -6,000.00
Jun 30, 2025 -25,000.00
Mar 31, 2025 -28,000.00
Dec 31, 2024 -18,000.00
Sep 30, 2024 -9,000.00
Jun 30, 2024 -15,000.00
Mar 31, 2024 -48,000.00
Dec 31, 2023 13,000.00
Sep 30, 2023 -1,000.00